Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III tri
about
Therapeutic interventions for Burkitt lymphoma in childrenNon-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges AheadHematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.Combination of dexamethasone, high-dose cytarabine, and carboplatin is effective for advanced large-cell non-Hodgkin lymphoma of childhood.Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma.Disease patterns of pediatric non-Hodgkin lymphoma: A study from a developing area in EgyptNon-anaplastic peripheral t-cell lymphoma in childhood and adolescence: a Children's Oncology Group study.Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies.Case report: A unique pediatric case of a primary CD8 expressing ALK-1 positive anaplastic large cell lymphoma of skeletal muscleALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/Akt activity with retained but inactivated PTEN--a report from the Children's Oncology Group.Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology groupNK/T-cell lymphomas in childrenIGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941.Palliative noninvasive ventilation in patients with acute respiratory failure.Anaplastic large cell lymphoma in children and adolescents.Therapeutic approaches to haematological malignancies in adolescents and young adults.Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.Non-Hodgkin Lymphoma in Children.Adolescent and young adult non-Hodgkin lymphoma.Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL.Anaplastic Large Cell Lymphoma in Central America: A Report From the Central American Association of Pediatric Hematology Oncology (AHOPCA).Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies.Clinical characteristics and treatment outcomes of children with anaplastic large cell lymphoma: a single center experience.Potential therapies for anaplastic lymphoma kinase-driven tumors in children: progress to dateFavourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: a report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group.Involvement of oncogenic tyrosine kinase NPM-ALK in trifluoperazine-induced cell cycle arrest and apoptosis in ALK(+) anaplastic large cell lymphoma.Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma.Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond.Treatment of pediatric lymphoma in Japan: Current status and plans for the future.
P2860
Q24235495-B08DE9CF-C4C1-43C2-B4A8-9054530F5133Q26797513-93469337-74F0-4459-BACA-E63257DC9B8CQ34025468-7E74321F-5416-41E1-A0EA-95F2D4CC7A86Q34287195-43DC333D-E0E0-459F-824B-A5187C99BACFQ34537366-533A83A6-C83E-4614-8713-E135F6178291Q34608129-03E343BC-B0BB-4AF1-A322-678E2FFD5F7DQ35661294-3958B74E-4E7F-42CB-9FF1-AB294256C662Q35667279-7004860A-E761-427F-90E2-BAEBEB970C23Q35984463-ED88871D-AAA9-4DEB-9EEC-D7AF93DC8254Q36094893-7A9BBDAE-9B1C-48FD-9B9B-8821C1E3ECE4Q36380013-B36E5023-C4EE-488A-AF2A-48AB5D56630EQ36995625-8987ADD4-FDE3-4950-8D96-FC04C52F80E6Q37271044-4E91F41E-1BB0-4EDD-AEAC-2F1CF9FC80F2Q37403652-74EB6568-07D5-4F47-A319-8C4098F61BAFQ37886851-88CDA9C6-8D51-4F05-9E8D-B52EC3E2E64AQ38113829-7288791D-356D-4BF5-9437-20BC4BBC51D8Q38134399-47BB2E7D-65E6-45B3-B0F1-0DDC26861835Q38207137-BC6F2A2E-6E80-4D4C-89EF-79FFAD38EB97Q38371659-2369DFDE-7C58-4D59-92B5-9622630E2D2CQ38547121-5B9CCE5E-0116-4635-A076-642951D5E092Q38806478-E18E8074-B155-480F-8EEC-F50F6C0E1562Q39271109-FE7E9BE8-8D3A-4F05-B7ED-4143CB5DCCADQ40643182-8F65B8FB-AA86-4E8D-BABD-C71A7824DBD7Q41942675-FA8CD4C9-CDEA-4106-A194-6C14DC987725Q42086879-5A64C364-06FC-4C20-AA8B-498716C473B6Q42694892-E5857AFA-0726-4413-AD60-33AC7849B31FQ46656073-216026D2-FAE5-477E-BB95-629418289785Q47396530-52E6835C-EA06-4F39-B043-62FC6D7CB3C9Q48187532-19EB01D8-9E3E-4E49-8F64-C708736F6113Q52619047-B216BA91-4EE1-4475-BA43-0885E9F6AE1DQ52935778-02CF77BC-6B11-46AD-B361-2AAC460D2B77
P2860
Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III tri
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Advanced-stage large-cell lymp ...... c Oncology Group phase III tri
@en
type
label
Advanced-stage large-cell lymp ...... c Oncology Group phase III tri
@en
prefLabel
Advanced-stage large-cell lymp ...... c Oncology Group phase III tri
@en
P2093
P356
P1476
Advanced-stage large-cell lymp ...... c Oncology Group phase III tri
@en
P2093
Howard J Weinstein
Jacqueline M Kraveka
James Kepner
Joseph H Laver
Molly Schwenn
Myron Chang
Nancy Tarbell
Robert E Hutchison
Sharon B Murphy
Sheila Weitzman
P304
P356
10.1200/JCO.2005.11.075
P407
P577
2005-01-01T00:00:00Z